In this video, Walter Koltun, MD, from Penn State Health, discusses how a patient’s diet can influence outcomes of ileal pouch–anal anastomosis, and more.
In this video, Walter Koltun, MD, from Penn State Health, discusses how a patient’s diet can influence outcomes of ileal pouch–anal anastomosis, and more.
In this video, Dr Hudesman, from NYU Langone Health, highlights the management of inflammatory bowel disease with nonmelanoma skin carcinoma and sun protection strategies.
In this video, Dr Hudesman, from NYU Langone Health, highlights the management of inflammatory bowel disease with nonmelanoma skin carcinoma and sun protection strategies.
In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy, discusses if anti-tumor necrosis factor agents increase the risk of new or...
In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy, discusses if anti-tumor necrosis factor agents increase the risk of new or...
In this video, Walter Koltun, MD, from Penn State Health, discusses what gastroenterologists should be telling their patients about the expected outcomes of ileal pouch–anal anastomosis.
In this video, Walter Koltun, MD, from Penn State Health, discusses what gastroenterologists should be telling their patients about the expected outcomes of ileal pouch–anal anastomosis.
In this video, Dr Rubin, from the University of Chicago, discusses the challenges in the management of dysplasia and preventing cancer in patients with ulcerative colitis.
In this video, Dr Rubin, from the University of Chicago, discusses the challenges in the management of dysplasia and preventing cancer in patients with ulcerative colitis.
In this video, Dr Rubin, from the University of Chicago, discusses the importance of screening and surveillance for dysplasia and colorectal cancer among patients with inflammatory bowel disease, and more.
In this video, Dr Rubin, from the University of Chicago, discusses the importance of screening and surveillance for dysplasia and colorectal cancer among patients with inflammatory bowel disease, and more.
Dr Ha, from Cedars-Sinai Medical Center, discusses the management of inflammatory bowel disease in the elderly, the potential for undertreatment, balancing medication interactions, and more.
Dr Ha, from Cedars-Sinai Medical Center, discusses the management of inflammatory bowel disease in the elderly, the potential for undertreatment, balancing medication interactions, and more.
In this video, Dr Aberra, from the University of Pennsylvania, discusses different types of infections that gastroenterologists should be aware of in inflammatory bowel disease (IBD), her own experience of treating a patient with IBD who...
In this video, Dr Aberra, from the University of Pennsylvania, discusses different types of infections that gastroenterologists should be aware of in inflammatory bowel disease (IBD), her own experience of treating a patient with IBD who...
Dr Hudesman, from NYU Langone Health, discusses when to withdraw medication among patients with inflammatory bowel disease, the risks associated with recurrence, if medication can be restarted, and more.
Dr Hudesman, from NYU Langone Health, discusses when to withdraw medication among patients with inflammatory bowel disease, the risks associated with recurrence, if medication can be restarted, and more.
Lindsey Albenberg, DO, from Children's Hospital of Philadelphia, discusses the role of the microbiome, as well as its influence on immunity and the development of pediatric inflammatory bowel disease.
Lindsey Albenberg, DO, from Children's Hospital of Philadelphia, discusses the role of the microbiome, as well as its influence on immunity and the development of pediatric inflammatory bowel disease.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...